全球静脉输液帮浦市场规模、份额、成长分析、按产品、按适应症划分 - 产业预测，2023-2030 年

Global Intravenous Infusion Pump Market Size, Share, Growth Analysis, By By Product(Volumetric Infusion Pumps, Insulin Infusion Pumps), By By Disease Indication(Chemotherapy, Diabetes) - Industry Forecast 2023-2030

出版日期: 2024年02月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球静脉输液帮浦市场规模估值为53亿美元，从2023年的57.4亿美元成长到2031年的108.6亿美元，在预测期间（2024-2031年）预计复合年增长率为8.3 %。

由于慢性病盛行率的增加、老年人口的快速成长以及医疗技术的进步，全球静脉输液帮浦市场呈现显着成长。这些帮浦在精确、受控地将液体、药物和营养物质直接输送到患者静脉中方面发挥着至关重要的作用。这项市场扩张的主要驱动因素包括对居家医疗服务的需求不断增长，特别是持续输液治疗，以及临床环境中精确给药的需求。此外，减少用药错误、提高病人安全和改善治疗结果的努力也有助于推动市场发展。输液帮浦市场的未来趋势将包括开拓直观、高度互连的设备，优先考虑患者安全和治疗效果，以及满足医疗保健专业人员和患者不断变化的需求的能力。这取决于资料-主导技术和以患者为中心的设计。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

贝克顿迪金森公司（美国）
B.Braun Melsungen AG（德国）
费森尤斯卡比股份公司（德国）
百特国际公司（美国）
美敦力公司（爱尔兰）
强生公司（美国）
泰尔茂株式会社（日本）
ICU 医疗公司（美国）
史密斯医疗（美国）
罗氏控股公司（瑞士）
穆格公司（美国）
尼普罗株式会社（日本）
Zyno医疗（美国）
迈瑞医疗国际有限公司 (中国)
泰利福公司（美国）
Hospira, Inc.（美国）
Halyard Health, Inc.（美国）
史密斯集团有限公司（英国）
维贡集团（法国）
麦克雷尔医疗器材公司（希腊）
凯撒利亚医疗电子有限公司（以色列）
赛诺医疗器材科技股份有限公司 (中国)
Tricumed Medizintechnik GmbH（德国）
库普德克（泰国）
Q Core 医疗有限公司（以色列）

简介目录

Product Code: SQMIG35A2492

Global Intravenous Infusion Pump Market size was valued at USD 5.3 billion in 2022 and is poised to grow from USD 5.74 billion in 2023 to USD 10.86 billion by 2031, growing at a CAGR of 8.3% during the forecast period (2024-2031).

The global market for intravenous (IV) infusion pumps has witnessed substantial growth, attributed to the increasing prevalence of chronic illnesses, a burgeoning elderly population, and advancements in medical technology. These pumps play a pivotal role in delivering fluids, medications, and nutrients directly into patients' veins with precision and control. Key drivers of this market expansion include the growing demand for home healthcare services, especially for continuous infusion therapies, and the imperative for precise drug administration in clinical environments. Additionally, efforts to mitigate medication errors, enhance patient safety, and improve treatment outcomes contribute to market momentum. The future trajectory of the IV infusion pump market hinges on the development of intuitive, interconnected devices prioritizing patient safety and treatment efficacy, as well as the ongoing integration of data-driven technologies and patient-centered designs to meet the evolving requirements of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Infusion Pump Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Infusion Pump Market Segmental Analysis

The Global Intravenous Infusion Pump Market is segmented on the basis of Product, Disease Indication, and region. By Product, the market is segmented into Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia (PCA), Implantable Infusion Pumps, Others. By Disease Indication, the market is segmented into Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Intravenous Infusion Pump Market

The rising occurrence of chronic conditions like cancer, diabetes, and cardiovascular ailments, combined with a worldwide aging demographic, fuels the necessity for intravenous (IV) infusion pumps. These tools play a vital role in precisely delivering medications, fluids, and nutrients to patients undergoing extended treatments, thereby enhancing disease control and fostering better patient results.

Restraints in the Global Intravenous Infusion Pump Market

Advanced intravenous infusion pumps, though highly effective, may pose significant financial challenges due to their expensive acquisition and maintenance costs, including calibration, upkeep, and training expenses. Such financial burdens can significantly strain healthcare budgets, posing a formidable barrier for healthcare facilities, especially in resource-limited settings or areas with constrained financial resources dedicated to healthcare.

Market Trends of the Global Intravenous Infusion Pump Market

The surge in Smart and Connected Infusion Pumps, which amalgamate technology and connectivity, marks a notable advancement in intravenous infusion systems. These intelligent pumps provide functionalities like dose calculation aid, seamless wireless integration with electronic health records (EHR) systems, and live monitoring of infusion metrics. This trend not only elevates patient safety but also enhances healthcare provider workflow efficiency, enabling remote monitoring and adjustments. The momentum towards digital healthcare solutions has spurred the uptake of smart infusion pumps, promising to mitigate medication errors and optimize the administration process.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Intravenous Infusion Pump Market by By Product

Market Overview
Volumetric Infusion Pumps
Insulin Infusion Pumps
Syringe Infusion Pumps
Enteral Infusion Pumps
Ambulatory Infusion Pumps
Patient Controlled Analgesia (PCA)
Implantable Infusion Pumps
and Others

Global Intravenous Infusion Pump Market by By Disease Indication

Market Overview
Chemotherapy
Diabetes
Gastroenterology
Analgesia/Pain Management
Pediatrics/Neonatology
Hematology
and Others

Global Intravenous Infusion Pump Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICU Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moog Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zyno Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hospira, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halyard Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vygon Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micrel Medical Devices SA (Greece)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caesarea Medical Electronics Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sino Medical-Device Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tricumed Medizintechnik GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coopdech (Thailand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Q Core Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments